Season 9 · Episode 9
S9 Ep9: FDA Approval Insights: Avapritinib in Indolent Systemic Mastocytosis
OncLive® On Air · OncLive® On Air
July 10, 202313m 53s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Gotlib discusses the significance of the FDA approval of avapritinib in indolent systemic mastocytosis, key findings from the PIONEER trial, and the quality of life benefits that avapritinib provides for patients in this population.